China Chemical Regulatory China International Trade & Investment Government Affairs & Public Policy
ISLN:
909931467
Admitted:
Chinese National Bar
Law School:
Nanjing University in Nanjing, China, LL.B., 1993; Shanghai Academy of Social Science, LL.M., 1999; The George Washington University Law School, LL.M., 2002
Washington Eye Clinic 416 W Las Tunas Dr STE 304, San Gabriel, CA 91776 (626)5882518 (phone)
Education:
Medical School Louisiana State University School of Medicine at New Orleans Graduated: 1998
Procedures:
Lens and Cataract Procedures
Conditions:
Cataract Glaucoma Keratitis Retinal Detachments
Languages:
Chinese English
Description:
Dr. Huang graduated from the Louisiana State University School of Medicine at New Orleans in 1998. He works in San Gabriel, CA and specializes in Ophthalmology. Dr. Huang is affiliated with San Gabriel Valley Medical Center.
Diesel Program at South Plains College Levelland, TX Aug 2014 to Dec 2014 Hydraulics & SchematicsSears Automotive Service Center Lubbock, TX Apr 2014 to Jul 2014 Lead Customer Service Adviser / Customers Experienced ManagerAutomotive Program at South Plains College Lubbock, TX Jan 2014 to May 2014 Gasoline Engine Remove, Repair, and Installation ClassesABCO Subsea Consultative Offshore Engineering Company
May 2013 to Aug 2013 Mechanical Engineer Intern
Education:
Texas Tech University Lubbock, TX 2009 to 2013 Bachelor of Science in Mechanical EngineeringCollin County Community College Plano, TX 2009 Associate in Pre-EngineeringTexas Tech University Lubbock, TX 2014 Master of Business and Administration
Skills:
Excel, Microsoft Office, PPT, Autodesk Inventor, a little bit of matlab
Tsz Simon Cheng - Grand Prairie TX, US Ying Huang - Westchester NY, US Santhosh Kumaran - Croton On Hudson NY, US Amaresh Rajasekharan - Cortlandt Manor NY, US Mathews Thomas - Flower Mound TX, US Frederick Y. Wu - Cos Cob CT, US Yiming Ye - White Plains NY, US
Assignee:
International Business Machines Corporation - Armonk NY
International Classification:
G06Q 30/00
US Classification:
705 26, 705 37
Abstract:
A software architecture can include an artifact layer and a configuration layer. The artifact layer can contain multiple application independent artifacts. A configuration layer can contain at least one application. The application can include multiple states in which the application executes instructions. The states can exist within execution spaces that are distributed across a network. The application uses artifacts of the artifact layer, which can operate in a state dependent manner.
Reference: Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial by Feng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, Jian-Ying Huang, Tao Jiang, Li-Hua Hou, Jing-Xin Li, Be
Date: Jul 20, 2020
Category: More news
Source: Google
Gilead Sciences, Inc Stock May Be in For a Rally Ahead of EASL
According to Merrill Lynch analyst Ying Huang who has also commented on the published abstracts Gileads 24-week sof/vel combo drug with or without ribavirin delivered a retreatment option for patients who failed initial treatment with the same combo med for 8-12 weeks. An 8-week triple combinat
Date: Apr 01, 2016
Category: Business
Source: Google
Cost of Gilead's hepatitis C pill, Sovaldi, spurs revolt
"It's just the sheer number of patients who have the disease. Multiply that number by that price," said Ying Huang, a senior biotechnology analyst at Barclays, whose clients include Gilead. "All of a sudden, you get a big number."
approved in 100 countries for kidney cancer and liver cancer, are split between Bayer and Onyx. The drug had sales of roughly $900 million last year. An expanded approval for thyroid cancer could result in an additional $300 million in peak global sales annually, said Ying Huang, a Barclays analyst.
Date: Jun 02, 2013
Category: Health
Source: Google
GlaxoSmithKline extends tender offer for Human Genome Sciences
"We continue to believe the most likely outcome will be a slightly higher bid from GSK, with no white knights coming to the table with a substantially higher bid," said Ying Huang and Brian Bourdot at Barclays Capital.